ADA/CD26 axis increases intra-tumor PD-1+CD28+CD8+ T-cell fitness and affects NSCLC prognosis and response to ICB
Article in OncoImmunology (June 2024)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Article in OncoImmunology (June 2024)
Article in Cells (May 2024)
Article in Frontiers in Oncology (May 2024)